Skip to main content
. 2016 Dec 23;13(3):1149–1156. doi: 10.3892/ol.2016.5529

Figure 3.

Figure 3.

Kaplan-Meier survival analysis curves showing OS times of breast cancer patients in the (A) high and (B) low Cbx2 expression groups, treated with or without Taxol. OS, overall survival; Cbx2, chromobox2.